Close
Digital Health & Ai Innovation summit 2026
Medical Taiwan 2026

Philips and SURFsara collaborate on big data platform

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Sterile Drug Production Strengthens Contamination Control

Detailed exploration of the advancements in aseptic processing and cleanroom management that are vital for the safety of injectable pharmaceuticals. The industry is currently moving toward a more holistic approach where contamination control is integrated into every aspect of the facility design and operational workflow to mitigate microbial risks.

Medical Device Innovation and Regulatory Strategy...

A comprehensive look at how the medical device sector is navigating the complex intersection of cutting-edge technology and increasingly stringent global regulations. The industry is currently shifting toward a more data-centric approach to compliance, where clinical validation and quality assurance are integrated into the earliest stages of product development.

Technology Trends Transform Pharmaceutical Manufacturing

Deep analysis of the shift toward automated, digital, and resilient production environments. The industry is currently witnessing a massive overhaul in how life-saving medications are developed and distributed, focusing heavily on smart factory integration and strict adherence to global regulatory standards.
  • Collaboration combines Philips’ expertise in health informatics and SURFsara’s capabilities in high performance supercomputing infrastructures
  • Via online portal combined cloud-based services will facilitate multicenter life sciences research and big data analytics to speed up the translation of academic research into healthcare innovation
Royal Philips and SURFsara the leading Dutch high-performance supercomputing and data infrastructure provider for education and academic research, today announced a new collaboration with the aim to connect the Philips HealthSuite cloud platform to the SURFsara National Research Infrastructure to provide new cloud-based research services.
The services will specifically support research into precision medicine and population health. An example are new targeted therapies for colon, prostate or breast cancer that require bringing together massive amounts of data from medical scanners, tissue biopsies, lab results and genomics over long periods of time to generate deep and comprehensive views on a patient’s individual situation. Studies into population health need to combine extremely large health data sets of large groups of people. These are analyzed to find even the smallest correlations and patterns that could eventually lead to new approaches to enable early intervention and improve treatments
“Today, hospitals can already retrieve massive amounts data from multiple sources and various disciplines, and through research obtain new clinical insights,” said Jeroen Tas, CEO Connected Care and Health Informatics at Philips. “But even greater value lies in combining, normalizing and analyzing the current islands of data. Our integrated services aim to combine data on all levels and connect health systems, clinical expertise and research programs in a secure and compliant manner. Through networked healthcare research we want to facilitate collaboration on the next generation of breakthroughs in care delivery.”
Via a user-friendly portal for online collaboration, data scientists and clinical researchers will have secure high-speed access to Big Data, supercomputing facilities, combined Philips and SURFsara analytics tools, machine learning technology and IT services. It aims to enable scientists and researchers to seamlessly move, share, combine and re-use extremely large sets of data available across academic medical institutions and research programs and analyze them in a compliant manner.
“SURFsara supports the national life science research with ICT experience and has a mission to connect business to research,” said Anwar Osseyran, SURFsara CEO and Professor of Business Analytics and Computer Science at the University of Amsterdam. “We will collaborate with Philips to enhance the cloud-base services of Philips and use these resources to make life science data available for science in the Netherlands and beyond.”
The comprehensive new translational research environment envisaged initially aims to facilitate academic medical institutions and research programs, and will later expand to support healthcare centers of excellence and life sciences scholars to analyze the vast amounts of data generated by disciplines such as genomics, digital pathology and imaging. The Big Data research services will be open to collaborative research initiatives throughout Europe and beyond, reflecting the global nature of modern-day connected healthcare research in a compliant manner.
The volume of stored clinical data is growing at around 40% per year due to rapid advancements in diagnostic medical imaging and patient monitoring, chronic disease management as well as the growing adoption of medical-grade IoT devices (unobtrusive sensors) that enable enhanced patient self-measurement and opens a new dimension in high quality data collection. An even greater data explosion is predicted as access to and analysis of digital pathology and genomics data becomes more widely adopted.
 
Joost Maltha
Philips Communications Healthcare Informatics Solutions and Services
Tel.: +31 610 55 8116
E-mail: Joost.Maltha@philips.com
Kathy O’Reilly
Philips Group Communications
Tel.: +1 978-659-2638
E-mail: Kathy.Oreilly@philips.com
Chantal Cassee
SURFsara Head of Communications
Tel: +31 623870050
E-mail: Chantal.cassee@surfsara.nl
 
About Royal Philips
Royal Philips is a leading health technology company focused on improving people’s health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. The company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Headquartered in the Netherlands, Philips’ health technology portfolio generated 2015 sales of EUR 16.8 billion and employs approximately 69,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.
About SURFsara
SURFsara has the national high performance infrastructure for academic research, medical centers and research institutions. We create the bridge between research and our advanced ICT. We do so with scientific research in our DNA and unique expertise contained in our large scale infrastructure. This enables us to boost scientific research with complex computational modeling and analytics and management of big data. We also focus on developing initiatives for the business community.SURFmarket, SURFnet and SURFsara are subsidiaries of the SURF cooperation, the collaborative ICT organization for Dutch education and research. SURF offers students, lecturers and scientists in the Netherlands access to the best possible internet and ICT facilities. For more information, visit www.surfsara.nl
MEDICAL FAIR ASIA 2026

Latest stories

Related stories

Sterile Drug Production Strengthens Contamination Control

Detailed exploration of the advancements in aseptic processing and cleanroom management that are vital for the safety of injectable pharmaceuticals. The industry is currently moving toward a more holistic approach where contamination control is integrated into every aspect of the facility design and operational workflow to mitigate microbial risks.

Medical Device Innovation and Regulatory Strategy Trends

A comprehensive look at how the medical device sector is navigating the complex intersection of cutting-edge technology and increasingly stringent global regulations. The industry is currently shifting toward a more data-centric approach to compliance, where clinical validation and quality assurance are integrated into the earliest stages of product development.

Technology Trends Transform Pharmaceutical Manufacturing

Deep analysis of the shift toward automated, digital, and resilient production environments. The industry is currently witnessing a massive overhaul in how life-saving medications are developed and distributed, focusing heavily on smart factory integration and strict adherence to global regulatory standards.

Biotech Innovation Strengthening Clinical Pipelines

The discovery and development of next-generation therapies are being propelled by a fundamental leap in our understanding of molecular biology and cellular mechanics. By bridging the gap between laboratory research and clinical application, the life sciences sector is creating a robust stream of precision treatments that offer new hope for previously intractable conditions.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »